Regulation of Radiopharmaceutical Products
The fast development of diagnostic and therapeutic radionuclide technologies requires enhanced legislative regulation of radiopharmaceuticals. The article addresses the challenge of classifying radiopharmaceuticals depending on the manufacturing technology, radionuclide properties, and clinical use....
Saved in:
| Main Authors: | V. V. Kosenko, A. A. Trapkova, S. N. Kalmykov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2022-12-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/501 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The main issues of quality assurance of radiopharmaceuticals
by: G. E. Kodina, et al.
Published: (2019-12-01) -
To be GMP or not to be– a radionuclide’s question
by: Clemens Decristoforo, et al.
Published: (2025-07-01) -
Radioactive gold nanocluster (198-AuNCs) showed inhibitory effects on cancer cells lines
by: Shijin Xuan, et al.
Published: (2020-01-01) -
Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
by: D. V. Goryachev, et al.
Published: (2025-02-01) -
Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01)